GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » PB Ratio

Halberd (Halberd) PB Ratio : (As of May. 22, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Halberd PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-22), Halberd's share price is $0.0088. Halberd's Book Value per Share for the quarter that ended in Jul. 2023 was $-0.00. Hence, Halberd's PB Ratio of today is .

The historical rank and industry rank for Halberd's PB Ratio or its related term are showing as below:

HALB's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.56
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Halberd PB Ratio Historical Data

The historical data trend for Halberd's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd PB Ratio Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
PB Ratio
- - -

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
PB Ratio - - -

Competitive Comparison of Halberd's PB Ratio

For the Biotechnology subindustry, Halberd's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Halberd's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's PB Ratio distribution charts can be found below:

* The bar in red indicates where Halberd's PB Ratio falls into.



Halberd PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Halberd's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jul. 2023)
=0.0088/-0.002
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Halberd  (OTCPK:HALB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Halberd PB Ratio Related Terms

Thank you for viewing the detailed overview of Halberd's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236